Abstract
The craniofacial region contains many specified tissues, including bone, cartilage, muscle, blood vessels, fat, skin and neurons. A defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient’s life. Therefore, functional reconstruction of damaged tissues is highly sought. The use of cell-based therapies represents one of the most advanced methods for enhancing the regenerative response for craniofacial wound-healing. The recently acquired ability to reprogram human adult somatic cells to induced pluripotent stem cells (iPSCs) in culture may provide a powerful tool for in vitro disease modeling and an unlimited source for cell replacement therapy. This review focuses on the generation, biological characterization and discussion of the potential application of iPSCs for craniofacial tissue-engineering applications.
Keywords: Cell differentiation, craniofacial reconstruction, embryonic stem cells, induced pluripotent stem cells, regenerative medicine, somatic cells.
Current Stem Cell Research & Therapy
Title:Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction
Volume: 9 Issue: 3
Author(s): Yao Fu, Shuwen Deng, Jing Wang, Zhaozhao Chen, Shu Zhang, Songtao Wu, Yan Jiang, Ling Ye, Qiang Peng and Yunfeng Lin
Affiliation:
Keywords: Cell differentiation, craniofacial reconstruction, embryonic stem cells, induced pluripotent stem cells, regenerative medicine, somatic cells.
Abstract: The craniofacial region contains many specified tissues, including bone, cartilage, muscle, blood vessels, fat, skin and neurons. A defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient’s life. Therefore, functional reconstruction of damaged tissues is highly sought. The use of cell-based therapies represents one of the most advanced methods for enhancing the regenerative response for craniofacial wound-healing. The recently acquired ability to reprogram human adult somatic cells to induced pluripotent stem cells (iPSCs) in culture may provide a powerful tool for in vitro disease modeling and an unlimited source for cell replacement therapy. This review focuses on the generation, biological characterization and discussion of the potential application of iPSCs for craniofacial tissue-engineering applications.
Export Options
About this article
Cite this article as:
Fu Yao, Deng Shuwen, Wang Jing, Chen Zhaozhao, Zhang Shu, Wu Songtao, Jiang Yan, Ye Ling, Peng Qiang and Lin Yunfeng, Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction, Current Stem Cell Research & Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574888X09666140213155800
DOI https://dx.doi.org/10.2174/1574888X09666140213155800 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Novel Inflammatory Indices in Aortic Disease
Current Medicinal Chemistry Treatment of Choroidal Neovascularization in High Myopia
Current Drug Targets Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Current Genomics Forensic DNA Phenotyping in Criminal Investigations and Criminal Courts: Assessing and Mitigating the Dilemmas Inherent in the Science
Recent Advances in DNA & Gene Sequences (Discontinued) Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Prevention of Cardiovascular Complications in the Marfan Syndrome
Vascular Disease Prevention (Discontinued) Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Current Genomics in Cardiovascular Medicine
Current Genomics Management and Outcomes of Aortic Dissection in Pregnancy with Marfan Syndrome: A Systematic Review
Current Vascular Pharmacology Endovascular Repair of Thoracic Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery Actions of Selected Cardiovascular Hormones on Arterial Stiffness and Wave Reflections
Current Pharmaceutical Design Statins in Aortic Disease
Current Pharmaceutical Design The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine Pleiotropic Effects of ARB in Vascular Metabolism - Focusing on Atherosclerosis-Based Cardiovascular Disease
Current Vascular Pharmacology Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Patents Relating to siRNAs and Therapeutic Strategies for Genetic Diseases
Recent Patents on DNA & Gene Sequences Arrhythmias and Left Ventricular Hypertrabeculation/Noncompaction
Current Pharmaceutical Design